MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
284 hedge funds and large institutions have $11.5B invested in Mirati Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 101 increasing their positions, 81 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
26% more funds holding
Funds holding: 225 → 284 (+59)
25% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 81
Holders
284
Holding in Top 10
13
Calls
$232M
Puts
$110M
Top Buyers
| 1 | +$191M | |
| 2 | +$151M | |
| 3 | +$136M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$89.1M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$80.1M |
Top Sellers
| 1 | -$206M | |
| 2 | -$160M | |
| 3 | -$37.7M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$37.7M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$36.9M |